In line with the trTregs and ILC2 responses, early infection in IL-33-treated mice progressed with a tendency toward reduced GOT and CPK levels, with no changes in LDH and GPT activity, or glucose concentrations (S7G Fig). The gene discussed is IL33; the disease is infection.